Value of therapeutic drug monitoring in the management of patients with HIV infection undergoing haemodialysis [4]

International Journal of STD and AIDS

Volumn 15, Issue 1, 2004, Pages 67-68

  Joseph, A T ^a   Khoo, S H ^b  

^a MANOR HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPRENAVIR; AMPRENAVIR PHOSPHATE; ANTIRETROVIRUS AGENT; COTRIMOXAZOLE; DIDANOSINE; EFAVIRENZ; LAMIVUDINE; LOPINAVIR; LOPINAVIR PLUS RITONAVIR; PROTEINASE; RITONAVIR; RNA DIRECTED DNA POLYMERASE; TENOFOVIR;

ADULT; ANAMNESIS; CASE REPORT; CLINICAL FEATURE; CODON; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG EFFICACY; DRUG MONITORING; FEMALE; HEMODIALYSIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNE RESPONSE; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY FAILURE; LABORATORY TEST; LETTER; PRIORITY JOURNAL; TREATMENT OUTCOME; VIRUS LOAD;

ADULT; AIDS-ASSOCIATED NEPHROPATHY; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CARBAMATES; DRUG MONITORING; FEMALE; HUMANS; PYRIMIDINONES; RENAL DIALYSIS; SULFONAMIDES;

EID: 0347302924     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/095646204322637335     Document Type: Letter

References (3)

1. Winston JA, Bruggeman LA, Ross MD, et al. Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection. N Engl J Med 2001;344:1979-84
2. Wali RK, Drachenberg CI, Papadimitriou JC, et al. HIV 1 associated nephropathy and response to highly active anti-retroviral therapy. Lancet 1998;352:783-4
3. Urban AW, Bean P, Aziz D, et al. Protease inhibitor drug levels in the management of HIV-1 anti-retroviral therapy. Int J STD AIDS 2003;14:103-8